Here are five things to know:
1. The $4.6 million equity will go toward the company’s working capital.
2. Twenty-three investors participated in the equity round.
3. TrackX is currently developing a medical device intended to decrease radiation exposure during surgeries, as reported by WRAL TechWire.
4. TrackX listed Robert Isaacs, MD, a Durham-based Duke Health neurosurgeon, as a company director and promoter on its recent Securities and Exchange Commission filing.
5. Dr. Isaacs completed his endoscopic and complex spine surgery fellowship at Rush University, Chicago Institute of Neurosurgery and Neuroresearch.
More articles on devices:
Medtronic, Exactech, RTI Surgical & more: 9 device company key notes
AxioMed president comments on outpatient cervical disc replacement study: 5 observations
North America leads global neurosurgery market — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
